Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. R. Improta
Basal Supplementation of Insulin Lispro Protamine Suspension Versus Insulin Glargine and Detemir for Type 2 Diabetes: Meta-Analysis of Randomized Controlled Trials
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Related publications
Use of Insulin Lispro Protamine Suspension in Pregnancy
Advances in Therapy
Medicine
Pharmacology
Glycemic Control During Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Insulin Injections in Type 2 Diabetes: Individual Patient Data Meta-Analysis and Meta-Regression of Randomized Controlled Trials
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
402: Basal Insulin Analogs Versus Neutral Protamine Hagedorn for Type 2 Diabetics
American Journal of Obstetrics and Gynecology
Gynecology
Obstetrics
A 26-Week, Randomized Trial of Insulin Detemir Versus NPH Insulin in Children and Adolescents With Type 2 Diabetes (iDEAt2)
European Journal of Pediatrics
Child Health
Pediatrics
Perinatology
A Randomized Trial Comparing Perinatal Outcomes Using Insulin Detemir or Neutral Protamine Hagedorn in Type 1 Diabetes
Journal of Maternal-Fetal and Neonatal Medicine
Gynecology
Child Health
Pediatrics
Perinatology
Obstetrics
Erratum To: Selenium Supplementation and the Risk of Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials
Endocrine
Randomized Controlled Trial of Insulin Supplementation for Correction of Bedtime Hyperglycemia in Hospitalized Patients With Type 2 Diabetes
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Premixed vs Basal-Bolus Insulin Regimen in Type 2 Diabetes: Comparison of Clinical Outcomes From Randomized Controlled Trials and Real-World Data
Diabetic Medicine
Internal Medicine
Endocrinology
Metabolism
Diabetes
Achieve Control: A Pragmatic Clinical Trial of Insulin Glargine 300 U/mL Versus Other Basal Insulins in Insulin-Naïve Patients With Type 2 Diabetes
Postgraduate Medicine
Medicine
